Clinical Trial Update: Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for peripheral blood allogenic stem cell transplantation using non-anti thymocyte globulin regimens in severe aplastic anemia, spanning Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Non-anti Thymocyte Globulin regimens for peripheral blood allogenic stem cell transplantation

Snippet

Sponsor: Assiut University | Conditions: Severe Aplastic Anemia | Phase 2, Phase 3 | Status: UNKNOWN